Association of Interstitial Lung Disease With Clinical Characteristics of Chinese Patients With Systemic Lupus Erythematosus

Yaling CHEN, Yanqing WANG, Xiangfang CHEN, Huishun LIANG, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2020.7583

Issue: Volume 35 - Issue 2 - June 2020
3094 1986

Retrospective Analysis of the Factors Affecting Growth Parameters in Turkish Children With Systemic Lupus Erythematosus

Sibel BALCI, Rabia Miray KIŞLA EKİNCİ, Engin MELEK, Aysun KARABAY BAYAZIT, Dilek DOĞRUEL, Derya UFUK ALTINTAŞ, Mustafa YILMAZ

DOI: 10.46497/ArchRheumatol.2020.7573

Issue: Volume 35 - Issue 3 - September 2020
2322 2142

Platelet Distribution Width Level in Patients With Systemic Lupus Erythematosus-Associated Pulmonary Arterial Hypertension and Its Diagnostic Value

Yuzhu HE, Yikai YU, Shaoxian HU

DOI: 10.46497/ArchRheumatol.2020.7791

Issue: Volume 35 - Issue 3 - September 2020
2542 1920

Pattern of Nailfold Capillaroscopy in Patients With Systemic Lupus Erythematosus

Ting ZHAO, Fu-an LIN, Hong-pu CHEN

DOI: 10.46497/ArchRheumatol.2020.7763

Issue: Volume 35 - Issue 4 - December 2020
3566 2431

Urinary soluble alpha chain of the interleukin-2 receptor as a biomarker of active lupus nephritis in Egyptian children with juvenile systemic lupus erythematosus

Waleed HASSAN, Eman BEHIRY, Marwa MAHGOUB

DOI: 10.46497/ArchRheumatol.2021.8001

Issue: Volume 36 - Issue 1 - March 2021
1798 2418

Imbalanced Innate Lymphoid Cells are Associated With Disease Activity and Arthritis Involvement in Patients With Systemic Lupus Erythematosus

Yanni JIANG, Yi ZHAO, Yi LIU, Qiaorong HUANG, Wentong MENG, Hong XU, Xianming MO

DOI: 10.46497/ArchRheumatol.2020.7440

Issue: Volume 35 - Issue 4 - December 2020
2059 1935

Experiences of Iranian female patients with systemic lupus erythematosus: A qualitative study

Zahra Behboodi MOGHADAM, Seyedeh Tahereh FAEZI, Armin ZAREIAN, Elham REZAEI

DOI: 10.46497/ArchRheumatol.2021.7989

Issue: Volume 36 - Issue 1 - March 2021
1543 1941

Association of vitamin D deficiency and disease activity in systemic lupus erythematosus patients: Two-year follow-up study

Ainan ARSHAD, Saad Bin Zafar MAHMOOD, Ahmed AYAZ, Adil Al Karim MANJI, Akash Kumar AHUJA

DOI: 10.46497/ArchRheumatol.2021.8178

Issue: Volume 36 - Issue 1 - March 2021
2169 2136

Factors associated with self-reported capacity to walk, jog and run in individuals with systemic lupus erythematosus

Gizem İrem KINIKLI, Susanne PETTERSSON, Sevilay KARAHAN, Iva GUNNARSSON, Elisabet SVENUNGSSON, Carina BOSTRÖM

DOI: 10.46497/ArchRheumatol.2021.8193

Issue: Volume 36 - Issue 1 - March 2021
1724 2144

Investigation of Genes Associated With Atherosclerosis in Patients With Systemic Lupus Erythematosus

Mehmet Ali BALCI, Engin ATLI, Hakan GüRKAN

DOI: 10.46497/ArchRheumatol.2021.8024

Issue: Volume 36 - Issue 2 - June 2021
1631 2457

Identification of sequence polymorphisms in the mitochondrial deoxyribonucleic acid displacement-loop region as risk factors for systemic lupus erythematosus

Ruixue Lai, Xiaoyun Zhang, Kuangyuan Qiao, Xueqing Gao, Shang Li, Ruixing Zhang, Yixin Qi, Chenxing Peng

DOI: 10.46497/ArchRheumatol.2021.8101

Issue: Volume 36 - Issue 3 - September 2021
2159 2089

Association of TNFAIP3 gene polymorphism (rs5029939) with susceptibility and clinical phenotype of systemic lupus erythematosus

Hala Gaballah, Reham Abd-elkhalek, Ola Hussein, Shimaa Abd El-wahab

DOI: 10.46497/ArchRheumatol.2022.8769

Issue: Volume 36 - Issue 4 - December 2021
1633 1855

Disease characteristics in patients with juvenile- and adult-onset systemic lupus erythematosus: A multi-center comparative study

Sherif M Gamal, Nermeen Fouad, Nora Yosry, Wael Badr, Nesreen Sobhy

DOI: 10.46497/ArchRheumatol.2022.8888

Issue: Volume 37 - Issue 2 - June 2022
2059 2181

Therapeutic Effects of Tofacitinib on Pristane-Induced Murine Lupus

Jiayi LIN, Yaqin ZHANG, Meihua WANG, Yang ZHANG, Pin LI, Yingping CAO, Xuwei YANG

DOI: 10.46497/ArchRheumatol.2022.8252

Issue: Volume 37 - Issue 2 - June 2022
2118 2682

Impact of vitamin D level and supplementation on systemic lupus erythematosus patients during COVID-19 pandemic

Yasmin Adel, Mohamed Elgamal, Sherehan Adel Abdelsalam

DOI: 10.46497/ArchRheumatol.2022.8996

Issue: Volume 37 - Issue 2 - June 2022
2081 2164

Evaluation of personality disorders using the structured clinical interview for DSM-5 personality disorders, quality of life, and disease activity in patients with systemic lupus erythematosus

Yunus Durmaz, İlker İlhanlı, Pınar Durmaz

DOI: 10.46497/ArchRheumatol.2022.9002

Issue: Volume 37 - Issue 3 - September 2022
1750 1849

Pregnancy outcomes between pregnant systemic lupus erythematosus patients with clinical remission and those with low disease activity: A comparative study

Worawit Louthrenoo, Thananant Trongkamolthum, Nuntana Kasitanon, Antika Wongthanee

DOI: 10.46497/ArchRheumatol.2022.9140

Issue: Volume 37 - Issue 3 - September 2022
1587 1249

Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients

Eman Eissa, Botros Morcos, Dalia Dorgham, Naglaa Kholoussi

DOI: 10.46497/ArchRheumatol.2022.9217

Issue: Volume 37 - Issue 3 - September 2022
1591 1325

The effects of glucocorticoid treatment on cardiovascular system in patients with systemic lupus erythematosus

Dominika Blachut, Brygida Przywara-Chowaniec, Jan Harpula, Andrzej Tomasik, Ewa Nowalany-Kozielska, Beata Morawiec

DOI: 10.46497/ArchRheumatol.2022.9255

Issue: Volume 37 - Issue 4 - December 2022
1465 1556

MT-CO1 expression in nine organs and tissues of different-aged MRL/lpr mice: Investigation of mitochondrial respiratory chain dysfunction at organ level in systemic lupus erythematosus pathogenesis

Xinglan Huang, Peng Yan, Xinghua Song, Suiying Zhang, Yuqiong Deng, Caifeng Huang, Xiaoqing Zhao, Sheng Liu, Xiping Cheng, Dongjiang Liao

DOI: 10.46497/ArchRheumatol.2022.9168

Issue: Volume 37 - Issue 4 - December 2022
1872 1826